The increasing focus on NUT carcinoma treatment options, expanding investment in the NUT cancer therapy market, and continuous innovation across the rare cancer treatment market are transforming the management of one of the world's most aggressive and uncommon cancers. NUT midline carcinoma (NMC) is a rare, fast-growing malignancy driven primarily by NUTM1 gene...